Physician profile
Michael D Bagg
NPI 1881641967
$21,764.33
in general payments reported to CMS, 2019-2025
48 companies · $1,506 in 2025
The $1,506 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,494 · 2021: $1,788 · 2022: $2,101 · 2023: $1,743 · 2024: $1,234 · 2025: $1,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,414 · Education: $69.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,413.88 |
| Education | $69.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,364.89 | 2019-2025 | Ams 700 Cxr Rte Kit, Lithovue, Axonics |
| Intuitive Surgical, INC. | $3,624.08 | 2019 | |
| Coloplast Corp | $2,014.74 | 2019-2024 | Porges Coloplast |
| Neotract INC. | $1,422.15 | 2019-2020 | |
| Astellas Pharma US INC | $979.81 | 2019-2025 | Myrbetriq, Xtandi, Padcev |
| Janssen Biotech, INC. | $629.89 | 2019-2024 | Erleada |
| Sumitomo Pharma America, INC. | $608.92 | 2023-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $608.14 | 2021-2024 | Axonics, Bulkamid |
| Teleflex LLC | $557.01 | 2021-2023 | Urolift |
| Merck Sharp & Dohme LLC | $503.48 | 2019-2025 | Lynparza, Keytruda, Bridion |
| Urogen Pharma, INC. | $411.29 | 2021-2025 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $341.61 | 2019-2024 | Provenge |
| Calyxo, INC. | $322.43 | 2023-2025 | Cvac Aspiration System |
| Abbvie INC. | $322.00 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $273.44 | 2020-2025 | Adstiladrin |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bagg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.